SRPT
Sarepta Therapeutics Inc
20.80$
+3.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,317.4% | -11,928.6% | -4,534.6% | -150.1% | -129.1% | -119.9% | 19.9% | -63.1% | -34.9% | -40.3% | -10.8% | -9.3% | |
| 37.8% | 418.8% | 103.5% | 5.2% | 4.1% | 6.4% | 5.0% | 5.4% | 4.5% | 3.6% | 2.0% | 2.0% | |
| 208.5% | 2,563.2% | 552.7% | 19.7% | 16.7% | 20.6% | 20.0% | 16.2% | 25.0% | 14.7% | 9.7% | 5.6% | |
| 238.4% | 2,608.2% | 564.7% | -58.9% | 25.4% | 71.9% | 33.0% | 4.5% | 40.3% | – | – | – | |
| -226.9% | 2,552.7% | -290.9% | -63.0% | -35.8% | -17.6% | 102.6% | -14.0% | -4.2% | -38.7% | -37.7% | 3.6% | |
| 274.9% | 385.7% | 126.7% | 13.7% | 21.4% | 15.7% | 15.2% | 5.5% | 3.5% | 7.0% | 7.7% | 4.6% | |
| -1,629.9% | 671.2% | -1,663.8% | -115.7% | -123.1% | 75.3% | -22.5% | 70.6% | -112.2% | -13.3% | 39.7% | 3.2% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | 63.2% | 53.0% | – | – | – | – | – | |
| 1,068.5% | 10,439.3% | 6,729.4% | 229.0% | 187.2% | -1.1% | -0.9% | -1.1% | – | 0.0% | 0.0% | -1.1% | |
| -1.0% | 1,357.0% | -140.3% | 368.6% | -1.2% | 64.3% | 53.9% | 43.3% | 32.6% | 0.0% | 0.0% | -7.4% | |
| 1,067.5% | 11,796.3% | 6,975.3% | 574.5% | 176.1% | 168.7% | 126.3% | 80.0% | 24.9% | 10.1% | 6.6% | -7.7% | |
| -1,879.8% | 538.9% | 776.9% | 308.7% | -76.1% | 124.2% | 123.7% | 87.5% | -122.2% | -43.6% | 35.5% | -13.8% | |
| -1,592.3% | -12,314.3% | -4,661.2% | -163.8% | -150.5% | -135.5% | 4.7% | -68.6% | -38.3% | -47.3% | -18.5% | -14.0% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.